BACKGROUND: Refractory out-of-hospital cardiac arrest (OHCA) treated with standard advanced cardiac life support (ACLS) has poor outcomes. Transport to hospital followed by in-hospital extracorporeal cardiopulmonary resuscitation (ECPR) initiation may improve outcomes. We performed a pooled individual patient data analysis of two randomised controlled trials evaluating ECPR based approach in OHCA. METHODS: The individual patient data from two published randomised controlled trials (RCTs) were pooled: ARREST (enrolled Aug 2019-June 2020; NCT03880565) and PRAGUE-OHCA (enrolled March 1, 2013-Oct 25, 2020; NCT01511666). Both trials enrolled patients with refractory OHCA and compared: intra-arrest transport with in-hospital ECPR initiation (invasive approach) versus continued standard ACLS. The primary outcome was 180-day survival with favourable neurological outcome (defined as Cerebral Performance Category 1-2). Secondary outcomes included: cumulative survival at 180 days, 30-day favourable neurological survival, and 30-day cardiac recovery. Risk of bias in each trial was assessed by two independent reviewers using the Cochrane risk-of-bias tool. Heterogeneity was assessed via Forest plots. FINDINGS: The two RCTs included 286 patients. Of those randomised to the invasive (n = 147) and standard (n = 139) groups, respectively: the median age was 57 (IQR 47-65) and 58 years (IQR 48-66), and the median duration of resuscitation was 58 (IQR 43-69) and 49 (IQR 33-71) minutes (p = 0.17). In a modified intention to treat analysis, 45 (32.4%) in the invasive and 29 (19.7%) patients in the standard arm survived to 180 days with a favourable neurological outcome [absolute difference (AD), 95% CI: 12.7%, 2.6-22.7%, p = 0.015]. Forty-seven (33.8%) and 33 (22.4%) patients survived to 180 days [HR 0.59 (0.43-0.81); log rank test p = 0.0009]. At 30 days, 44 (31.7%) and 24 (16.3%) patients had favourable neurological outcome (AD 15.4%, 5.6-25.1%, p = 0.003), 60 (43.2%), and 46 (31.3%) patients had cardiac recovery (AD: 11.9%, 0.7-23%, p = 0.05), in the invasive and standard arms, respectively. The effect was larger in patients presenting with shockable rhythms (AD 18.8%, 7.6-29.4; p = 0.01; HR 2.26 [1.23-4.15]; p = 0.009) and prolonged CPR (>45 min; HR 3.99 (1.54-10.35); p = 0.005). INTERPRETATION: In patients with refractory OHCA, the invasive approach significantly improved 30- and 180-day neurologically favourable survival. FUNDING: None.

Center for Resuscitation Medicine University of Minnesota Medical School Minneapolis MN USA

Czech Institute of Informatics Robotics and Cybernetics Czech Technical University Prague Czech Republic

Department of Emergency Medicine Medical College of Wisconsin Milwaukee WI USA

Department of Emergency Medicine St Paul's Hospital and University of British Columbia 1081 Burrard St Vancouver BC Canada

Department of Intensive Care Hôpital Universitaire de Bruxelles Route de Lennik 808 Brussels 1070 Belgium

Department of Medicine Department of Cardiovascular Medicine General University Hospital and 1 Faculty of Medicine Charles University Prague Czech Republic

See more in PubMed

Soar J., Böttiger B.W., Carli P., et al. European resuscitation council guidelines 2021: adult advanced life support. Resuscitation. 2021;161:115–151. PubMed

Panchal A.R., Bartos J.A., Cabañas J.G., et al. Part 3: adult basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2020;142(16_suppl_2):S366–S468. PubMed

Empana J.-P., Lerner I., Valentin E., et al. Incidence of sudden cardiac death in the European Union. J Am Coll Cardiol. 2022;79(18):1818–1827. PubMed

Tsao C.W., Aday A.W., Almarzooq Z.I., et al. Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153–e639. PubMed

Bartos J.A., Grunau B., Carlson C., et al. Improved survival with extracorporeal cardiopulmonary resuscitation despite progressive metabolic derangement associated with prolonged resuscitation. Circulation. 2020;141(11):877–886. PubMed PMC

Yannopoulos D., Bartos J., Raveendran G., et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396(10265):1807–1816. PubMed PMC

Belohlavek J., Smalcova J., Rob D., et al. Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest: a randomized clinical trial. JAMA. 2022;327(8):737–747. PubMed PMC

Demets D.L. Methods for combining randomized clinical trials: strengths and limitations. Stat Med. 1987;6(3):341–348. PubMed

Bangdiwala S.I., Bhargava A., O'Connor D.P., et al. Statistical methodologies to pool across multiple intervention studies. Transl Behav Med. 2016;6(2):228–235. PubMed PMC

Sterne J.A.C., Savović J., Page M.J., et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. PubMed

Yannopoulos D., Kalra R., Kosmopoulos M., et al. Rationale and methods of the advanced R2Eperfusion STrategies for refractory cardiac arrest (ARREST) trial. Am Heart J. 2020;229:29–39. PubMed

Belohlavek J., Kucera K., Jarkovsky J., et al. Hyperinvasive approach to out-of hospital cardiac arrest using mechanical chest compression device, prehospital intraarrest cooling, extracorporeal life support and early invasive assessment compared to standard of care. A randomized parallel groups comparative study proposal. “Prague OHCA study”. J Transl Med. 2012;10:163. PubMed PMC

Sakamoto T., Morimura N., Nagao K., et al. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest: a prospective observational study. Resuscitation. 2014;85(6):762–768. PubMed

Goto T., Morita S., Kitamura T., et al. Impact of extracorporeal cardiopulmonary resuscitation on outcomes of elderly patients who had out-of-hospital cardiac arrests: a single-centre retrospective analysis. BMJ Open. 2018;8(5) PubMed PMC

Mørk S.R., Bøtker M.T., Christensen S., Tang M., Terkelsen C.J. Survival and neurological outcome after out-of-hospital cardiac arrest treated with and without mechanical circulatory support. Resusc Plus. 2022;10 PubMed PMC

Yannopoulos D., Bartos J.A., Aufderheide T.P., et al. The evolving role of the cardiac catheterization laboratory in the management of patients with out-of-hospital cardiac arrest: a scientific statement from the American Heart Association. Circulation. 2019;139(12):e530–e552. PubMed

Bartos J.A., Carlson K., Carlson C., et al. Surviving refractory out-of-hospital ventricular fibrillation cardiac arrest: critical care and extracorporeal membrane oxygenation management. Resuscitation. 2018;132:47–55. PubMed

Tonna J.E., Selzman C.H., Bartos J.A., et al. The association of modifiable postresuscitation management and annual case volume with survival after extracorporeal cardiopulmonary resuscitation. Crit Care Explor. 2022;4(7) PubMed PMC

Grunau B., Singh G., Bělohlávek J., et al. A second chance for survival: clinical trial evidence, eligibility, and barriers to implementation of ECPR for out-of-hospital cardiac arrest. Can J Cardiol. 2022;39(4):381–384. PubMed

Suverein M.M., Delnoij T.S.R., Lorusso R., et al. Early extracorporeal CPR for refractory out-of-hospital cardiac arrest. N Engl J Med. 2023;388(4):299–309. PubMed

Yannopoulos D., Bartos J.A., Raveendran G., et al. Coronary artery disease in patients with out-of-hospital refractory ventricular fibrillation cardiac arrest. J Am Coll Cardiol. 2017;70(9):1109–1117. PubMed

Yannopoulos D., Bartos J.A., Martin C., et al. Minnesota resuscitation consortium’s advanced perfusion and reperfusion cardiac life support strategy for out-of-hospital refractory ventricular fibrillation. J Am Heart Assoc. 2016;5(6) PubMed PMC

Hsu C.H., Meurer W.J., Domeier R., et al. Extracorporeal cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest (EROCA): results of a randomized feasibility trial of expedited out-of-hospital transport. Ann Emerg Med. 2021;78(1):92–101. PubMed PMC

Grunau B., Kime N., Leroux B., et al. Association of intra-arrest transport vs continued on-scene resuscitation with survival to hospital discharge among patients with out-of-hospital cardiac arrest. JAMA. 2020;324(11):1058–1067. PubMed PMC

Extracorporeal cardiopulmonary resuscitation versus standard treatment for refractory out-of-hospital cardiac arrest: a Bayesian meta-analysis

Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation and immediate invasive assessment in refractory out-of-hospital cardiac arrest: a long-term follow-up of the Prague OHCA trial

Wolf Creek XVII Part 7: Mechanical circulatory support

Extracorporeal cardiopulmonary resuscitation for refractory OHCA: lessons from three randomized controlled trials-the trialists' view